Libertini, Silvana <br/><br/>
AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947.  [electronic resource] 

 -  Endocrine-related cancer  Feb 2011 
 - 129-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1479-6821 
<br/><br/><label>Standard No.: </label>10.1677/ERC-10-0234  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Cell Death--drug effects<br/>Cell Proliferation--drug effects<br/>Combined Modality Therapy<br/>Drug Synergism<br/>Female<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Oncolytic Virotherapy<br/>Oncolytic Viruses--physiology<br/>Organophosphates--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Quinazolines--pharmacology<br/>Thyroid Carcinoma, Anaplastic<br/>Thyroid Neoplasms--pathology<br/>Tumor Cells, Cultured<br/>Up-Regulation--drug effects<br/>Xenograft Model Antitumor Assays